Necessity of Oligonucleotide Fragment Purification
Oligonucleotides, a term denoting short nucleotide chains with less than 20 bases, possess an innate propensity for
facile hybridization with their complementary counterparts. This feature underpins their common utility as molecular
probes, finding application in elucidating the structural characteristics of DNA or RNA, evident in techniques such as
gene chips, electrophoresis, and fluorescence in situ hybridization. Yet, the process of designing an accurate
oligonucleotide sequence can be intricate. The synthesis of oligonucleotides frequently engenders the inadvertent
emergence of impurities. These impurities bear the potential to perturb experimental outcomes, either through
competitive interaction with the intended full-length product or by constraining the desired reactions. Consequently,
the implementation of purification protocols becomes indispensable to ensure the fidelity of oligonucleotide samples
intended for experimental deployment.
Custom Carbohydrate Synthesis is one of the key services we have
been focusing on. CD BioGlyco with many chemists offers advanced custom carbohydrate synthesis for global clients. At
CD BioGlyco, we provide oligonucleotide fragment purification services through multiple advanced technologies, some of
which are shown below.
Desalination-based oligonucleotide fragment purification Desalting stands as a fundamental purification
technique employing both normal phase and reverse phase chromatography. Its primary purpose is the removal of
surplus salts from a mixture, yielding a salt-free DNA solution that is readily applicable. The resulting purified
oligosaccharides adhere to the prerequisites of various experiments, including applications like microarrays and
more.
Oligonucleotide purification cartridge (OPC)-based oligonucleotide fragment purification service The OPC column
is equipped with a resin that has an affinity for DMT. When synthesizing DNA fragments, the DMT on the last base at
the 5' end is retained. After all the synthetic products are adsorbed on the OPC column, wash the column with a
dilute organic solvent. Fragments have strong adsorption ability and are not easy to be eluted. Fragments without
DMT have weak adsorption ability and are eluted. Then trifluoroacetic acid or trichloroacetic acid is used to remove
the DMT group, and then elute the DNA by a concentrated organic solvent. This method has the characteristics of fast
and easy.
HPLC-based oligonucleotide fragment purification service This approach is well-suited for experiments demanding
elevated oligonucleotide purity, encompassing applications like directed mutagenesis, quantitative gene detection,
and diagnostic assays. For the purification of oligonucleotides, either anion exchange resins or reverse resins are
employed. High-performance liquid chromatography (HPLC) conducted with anion exchange resins routinely attains
purification efficiencies in the range of 95-98%. This method is marked by its substantial degree of automation,
swiftness, and the attainment of elevated product purity levels.
PAGE-based oligonucleotide fragment purification service PAGE purification is to distinguish the target
sequence from the failure sequence according to the size and conformation. The technique utilizes the different
charges and electrophoretic mobility of long and short fragments to separate them. Purified oligosaccharides
produced by this technique are commonly used in X-ray crystallography, gene synthesis, and mutagenesis studies.
Our purification process is a rigorous, multi-stage workflow tailored to each project's unique requirements to ensure
the highest possible quality.
Crude Oligonucleotide Receipt and Desalting
The process begins with the receipt of the crude oligonucleotide synthesis product. The initial step is a
comprehensive desalting procedure to remove small molecular weight impurities, such as synthesis byproducts and salts,
which can interfere with subsequent purification steps.
Primary Purification
The desalted product undergoes a primary purification step using a chosen advanced technology, such as RP-HPLC. The
trityl-on method is often used here, allowing us to specifically isolate the full-length oligonucleotide from shorter,
truncated sequences.
Final Detritylation and Isolation
After primary purification, the protective trityl group is removed from the isolated full-length fragment. The
product is then meticulously collected and prepared for the next stage.
Secondary Purification and Quality Control
Depending on the purity required, a second purification step, such as AE-HPLC, may be performed to ensure the
highest-grade product. The final purified oligonucleotide is then subjected to a battery of quality control tests,
including mass spectrometry to verify molecular weight and analytical HPLC to confirm purity.
Publication Data
DOI.: 10.1016/j.tet.2023.133774
Journal: Tetrahedron
Published: 2024
IF: 2.2
Results: In this study, the authors developed a simplified purification method for therapeutic
oligonucleotides synthesized via solid-phase synthesis. Their strategy addresses the challenge of removing
difficult "shortmer" impurities (incomplete sequences). Instead of using standard acetic anhydride as a capping
reagent during synthesis, they employed a highly lipophilic phosphoramidite reagent to modify the oligonucleotide's
5'-end. This modification significantly increases the retention of shortmer impurities on a reversed-phase HPLC
column compared to the desired full-length oligonucleotide. Consequently, the target oligonucleotide can be
selectively eluted in a simple step using a standard reversed-phase HPLC pretreatment column, enabling efficient
separation from the shortmers.
Applications
Genetic research: Purified oligonucleotide fragments are essential for genetic research, including PCR, DNA
sequencing, and mutation analysis. Accurate and reliable fragment purification ensures the integrity of genetic
information and enhances the accuracy of experimental outcomes.
Gene editing and CRISPR-Cas9 technology: In gene editing applications like CRISPR-Cas9, precise purification of
oligonucleotide fragments ensures the accuracy of gene modification. Purified fragments are used as guides or
templates for targeted gene editing processes.
Diagnostic assays: Purified oligonucleotide fragments play a key role in diagnostic assays, such as nucleic
acid-based tests for the detection of pathogens, genetic markers, and mutations. Highly purified fragments are
essential to avoid false positives or negatives.
Functional genomics: Oligonucleotide fragments are used to study gene expression, protein-DNA interactions, and
other molecular mechanisms. Purified fragments are critical for obtaining reliable and reproducible results in
functional genomics experiments.
Improved sensitivity: Highly purified oligonucleotide fragments increase the sensitivity of diagnostic assays and
research experiments. Minimizing background noise and interference enhances the detection of target sequences or
interactions.
Facilitates therapeutic development: For applications in drug discovery and development, such as antisense
oligonucleotide therapeutics, the purity of oligonucleotide fragments is crucial for safety and efficacy.
Purification ensures the removal of potential contaminants that could lead to adverse effects.
Time and cost savings: Outsourcing oligonucleotide fragment purification to specialized services saves time and
resources.
Frequently Asked Questions
Associated Services
To unlock advanced functionality building upon this high-purity foundation, our associated services enable
site-specific base modifications, including:
At CD BioGlyco, our Custom Oligonucleotide Synthesis service ensures the precise design and construction of oligonucleotides tailored
to your specific research needs. Utilizing cutting-edge technologies, our experts purify high-quality
oligonucleotides, enabling you to advance your research with confidence. If you are interested in our services,
please do not hesitate to contact us for more details.
Reference
Ren, Q.; et al. Development of simple purification method for oligonucleotides synthesized using
phosphoramidite for 5'-end modification as capping reagent. Tetrahedron. 2024, 150: 133774. (Open
Access)
This service is for Research Use Only, not intended for any clinical use.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.